A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos

Fecha de publicación: 30 de septiembre de 2026, 14:30

The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.